In vitro antileukaemic activity of extracts from berry plant leaves against sensitive and multidrug resistant HL60 cells

Katarzyna Skupień, Jan Oszmiański, Dorota Kostrzewa-Nowak, Jolanta Tarasiuk
Cancer Lett . 2006 May 18;236(2):282-91.

The aim of the present study was to determine in vitro antileukaemic activity of extracts obtained from selected berry plant leaves (Fragaria x ananassa Duch. cv Elsanta, raspberry Rubus ideus L. cv Polana and blueberry Vaccinium corymbosum L. cv Bluecrop) against promyelocytic HL60 cell line and its multidrug resistant sublines exhibiting two different MDR phenotypes: HL60/VINC (overexpressing P-glycoprotein) and HL60/DOX (overexpressing MRP1 protein). It was found that the blueberry extract was the most efficient against sensitive HL60 cell line (about 2-fold more active than strawberry and raspberry extracts) but presented much lower activity towards resistant cells. In contrast, strawberry and raspberry extracts exhibited the high cytotoxic activity against sensitive leukaemia HL60 cell line as well as its MDR sublines. The values of resistance factor (RF) found for these extracts were very low lying in the range 0.32/2.0.

Latest Cancer


Postdiagnostic Fruit and Vegetable Consumption and Breast Cancer Survival: Prospective Analyses in the Nurses’ Health Studies

Maryam S Farvid, Michelle D Holmes, Wendy Y Chen, Bernard A Rosner, Rulla M Tamimi, Walter C Willett, A Heather Eliassen
Cancer Res . 2020 Nov 15;80(22):5134-5143.
Read More

Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin

H Lamdan, R S Garcia-Lazaro, N Lorenzo, L G Caligiuri, D F Alonso, H G Farina
Exp Oncol . 2020 Jun;42(2):101-108.
Read More

Beyond Conventional Medicine – a Look at Blueberry, a Cancer-Fighting Superfruit

Kristoffer T Davidson, Ziwen Zhu, Dean Balabanov, Lei Zhao, Mark R Wakefield, Qian Bai, Yujiang Fang
Pathol Oncol Res . 2018 Oct;24(4):733-738.
Read More